Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

21.67 

0.21 1.0%

as of Aug 16 '19

52 Week Range:

20.43 48.77


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, and pediatric surgeons, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of December 31, 2018, it had a network of approximately 4,210 affiliated physicians. The company was founded in 1979 and is based in Sunrise, Florida.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 10.57
12.67
15.10
16.98
20.35
22.07
26.08
24.89
28.46
31.12
34.34
growth rate 19.9% 19.2% 12.5% 19.9% 8.5% 18.2% -4.6% 14.3% 9.4% 10.4%
Earnings BIT 241.42
287.70
311.15
353.25
388.17
448.41
513.00
557.87
571.69
480.08
445.85
growth rate 19.2% 8.2% 13.5% 9.9% 15.5% 14.4% 8.8% 2.5% -16.0% -7.1%
Avg.PE 10.19
15.90
15.80
16.13
16.39
19.23
22.43
17.72
20.08
19.12
12.53
growth rate 56.0% -0.6% 2.1% 1.6% 17.3% 16.6% -21.0% 13.3% -4.8% -34.5%
ROA 12.09
11.04
10.88
10.12
9.59
9.67
9.53
8.25
6.57
5.72
4.55
growth rate -8.7% -1.5% -7.0% -5.2% 0.8% -1.5% -13.4% -20.4% -12.9% -20.5%
ROE 17.59
16.31
15.37
13.72
12.79
12.81
13.77
14.31
12.50
11.00
8.73
growth rate -7.3% -5.8% -10.7% -6.8% 0.2% 7.5% 3.9% -12.7% -12.0% -20.6%
ROIC 16.60
15.14
14.45
13.13
12.33
12.48
12.41
10.71
8.92
8.07
6.68
growth rate -8.8% -4.6% -9.1% -6.1% 1.2% -0.6% -13.7% -16.7% -9.5% -17.2%
Cur. Ratio 0.90
0.84
0.92
1.33
1.34
1.25
1.12
1.23
1.31
1.18
1.31
growth rate -6.7% 9.5% 44.6% 0.8% -6.7% -10.4% 9.8% 6.5% -9.9% 11.0%
Quick Ratio 0.62
0.58
0.70
1.00
1.03
0.99
0.98
1.18
1.25
1.08
1.20
growth rate -6.5% 20.7% 42.9% 3.0% -3.9% -1.0% 20.4% 5.9% -13.6% 11.1%
Leverage 1.55
1.42
1.41
1.31
1.35
1.30
1.59
1.87
1.93
1.91
1.92
growth rate -8.4% -0.7% -7.1% 3.1% -3.7% 22.3% 17.6% 3.2% -1.0% 0.5%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 162.40
164.40
181.40
300.70
317.10
316.16
352.19
444.74
495.28
504.00
542.27
growth rate 1.2% 10.3% 65.8% 5.5% -0.3% 11.4% 26.3% 11.4% 1.8% 7.6%
Acct.Payable 254.16
268.24
326.70
32.78
21.97
28.47
34.63
31.06
growth rate 5.5% 21.8% -90.0% -33.0% 29.6% 21.6% -10.3%
Cur.Assets 284.90
292.70
296.00
337.27
359.04
368.13
467.05
527.77
587.13
627.24
657.41
growth rate 2.7% 1.1% 13.9% 6.5% 2.5% 26.9% 13.0% 11.3% 6.8% 4.8%
Total Assets 1,496.90
1,689.40
2,037.60
2,272.65
2,750.34
3,008.72
3,608.25
4,547.21
5,339.40
5,867.28
5,934.91
growth rate 12.9% 20.6% 11.5% 21.0% 9.4% 19.9% 26.0% 17.4% 9.9% 1.2%
Cash 14.30
26.50
26.30
18.60
21.28
31.14
47.93
51.57
55.70
60.20
36.75
growth rate 85.3% -0.8% -29.3% 14.4% 46.3% 53.9% 7.6% 8.0% 8.1% -39.0%
Inventory 0.00 0.00 0.00 0.00 0.00
growth rate
Cur.Liabilities 317.10
346.70
320.80
254.30
268.34
326.79
416.27
428.77
448.95
531.43
500.19
growth rate 9.3% -7.5% -20.7% 5.5% 21.8% 27.4% 3.0% 4.7% 18.4% -5.9%
Liabilities 531.70
499.30
590.20
541.63
714.97
665.73
1,342.68
2,109.37
2,578.63
2,800.82
2,847.03
growth rate -6.1% 18.2% -8.2% 32.0% -6.9% 101.7% 57.1% 22.3% 8.6% 1.7%
LT Debt 139.90
50.20
146.60
29.33
144.23
27.14
557.45
1,260.40
1,682.13
1,851.00
1,974.09
growth rate -64.1% 192.0% -80.0% 391.8% -81.2% 1,953.8% 126.1% 33.5% 10.0% 6.7%
Equity 965.10
1,190.10
1,447.50
1,731.02
2,035.37
2,342.99
2,264.62
2,437.53
2,760.77
3,066.45
3,087.88
growth rate 23.3% 21.6% 19.6% 17.6% 15.1% -3.3% 7.6% 13.3% 11.1% 0.7%
Common Shares 94.00
93.00
95.00
98.00
99.00
101.00
100.00
94.00
93.00
93.00
92.00
growth rate -1.1% 2.2% 3.2% 1.0% 2.0% -1.0% -6.0% -1.1% 0.0% -1.1%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 15.70
14.90
12.10
31.33
14.50
15.65
18.06
27.07
39.26
49.31
48.87
growth rate -5.1% -18.8% 158.9% -53.7% 8.0% 15.4% 49.9% 45.0% 25.6% -0.9%
Cash Dividends 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA 181.40
241.40
240.60
270.67
324.91
405.40
422.64
368.70
443.78
511.38
289.93
growth rate 33.1% -0.3% 12.5% 20.0% 24.8% 4.3% -12.8% 20.4% 15.2% -43.3%
FCF per Share 1.76
2.44
2.40
2.43
3.13
3.53
3.67
4.37
4.09
4.34
3.26
growth rate 38.6% -1.6% 1.3% 28.8% 12.8% 4.0% 19.1% -6.4% 6.1% -24.9%
Sale Purchase of Stock 31.36
28.81
-23.17
42.88
20.13
22.02
23.28
growth rate -8.1% -100.0% 100.0% -53.1% 9.4% 5.7%
FCF 166.00
226.00
228.00
240.00
311.00
390.00
405.00
342.00
405.00
462.00
241.00
growth rate 36.1% 0.9% 5.3% 29.6% 25.4% 3.9% -15.6% 18.4% 14.1% -47.8%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 1,068.30
1,288.30
1,401.60
1,588.25
1,816.61
2,154.01
2,438.91
2,780.00
3,183.16
3,458.31
3,647.12
growth rate 20.6% 8.8% 13.3% 14.4% 18.6% 13.2% 14.0% 14.5% 8.6% 5.5%
Op.Income 242.00
288.90
312.90
218.00
240.91
280.52
513.00
557.87
571.69
480.08
445.85
growth rate 19.4% 8.3% -30.3% 10.5% 16.4% 82.9% 8.8% 2.5% -16.0% -7.1%
IBT 241.40
287.70
311.20
353.25
388.17
448.41
508.62
539.73
513.80
410.42
368.84
growth rate 19.2% 8.2% 13.5% 9.9% 15.5% 13.4% 6.1% -4.8% -20.1% -10.1%
Net Income 169.20
175.80
202.70
218.00
240.91
280.52
317.28
336.32
324.91
320.37
268.63
growth rate 3.9% 15.3% 7.6% 10.5% 16.4% 13.1% 6.0% -3.4% -1.4% -16.2%
EPS 1.79
1.89
2.13
2.23
2.42
2.78
3.18
3.58
3.49
3.45
2.93
growth rate 5.6% 12.7% 4.7% 8.5% 14.9% 14.4% 12.6% -2.5% -1.2% -15.1%
Gross Profit 380.10
452.50
489.10
551.04
613.88
710.31
834.32
959.61
1,071.52
1,042.66
1,032.41
growth rate 19.1% 8.1% 12.7% 11.4% 15.7% 17.5% 15.0% 11.7% -2.7% -1.0%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 128.68
109.16
103.57
82.00
107.98
growth rate -15.2% -5.1% -20.8% 31.7%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 528.00
522.83
542.27
522.64
504.19
growth rate -1.0% 3.7% -3.6% -3.5%
Acct.Payable 28.38
30.71
31.06
32.15
386.41
growth rate 8.2% 1.1% 3.5% 1,101.9%
Cur.Assets 624.93
625.40
657.41
1,057.42
576.93
growth rate 0.1% 5.1% 60.9% -45.4%
Total Assets 5,859.64
5,838.72
5,934.91
5,706.26
5,638.81
growth rate -0.4% 1.7% -3.9% -1.2%
Cash 38.06
34.46
36.75
26.48
40.24
growth rate -9.5% 6.6% -28.0% 52.0%
Inventory
growth rate
Cur.Liabilities 411.21
435.94
500.19
415.18
414.69
growth rate 6.0% 14.7% -17.0% -0.1%
Liabilities 2,672.72
2,823.42
2,847.03
2,926.45
2,913.78
growth rate 5.6% 0.8% 2.8% -0.4%
LT Debt 1,891.11
2,005.96
1,974.09
2,119.48
2,080.12
growth rate 6.1% -1.6% 7.4% -1.9%
Equity 3,186.92
3,015.31
3,087.88
2,779.81
2,725.03
growth rate -5.4% 2.4% -10.0% -2.0%
Common Shares 0.93
0.89
0.88
0.86
2,725.03
growth rate -4.4% -1.7% -1.6% 315,296.6%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 13.85
11.86
10.73
5.82
growth rate -14.4% -9.5% -45.8%
Cash Dividends
growth rate
Cash From OA 135.24
140.73
127.59
-56.82
growth rate 4.1% -9.3% -100.0%
Sale Purchase of Stock 5.66
growth rate
FCF 121.39
128.87
116.86
-62.64
growth rate 6.2% -9.3% -100.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 915.92
896.65
932.70
851.18
868.31
growth rate -2.1% 4.0% -8.7% 2.0%
Op.Income 128.68
109.16
103.57
82.00
107.98
growth rate -15.2% -5.1% -20.8% 31.7%
IBT 109.53
90.45
81.37
50.62
52.63
growth rate -17.4% -10.0% -37.8% 4.0%
Net Income 79.41
65.58
60.21
-242.87
-8.25
growth rate -17.4% -8.2% -100.0% 0.0%
EPS
growth rate
Gross Profit 263.11
240.78
289.15
203.85
231.33
growth rate -8.5% 20.1% -29.5% 13.5%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (23.55)

YOY Growth Grade:

C (59.54)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 10.01 7.40 7.33
EPS / Growth 8.0% 2.93 13.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 7.8%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 7.8% 9.6% 9.6%
Future PE 7.33 12.18 12.18
Future EPS 6.19 7.33 7.33
Value Price
MOS %
11.22
-48.2%
22.06
1.8%
22.06
1.8%
MOS Price 5.61 11.03 11.03
IRT 5.70 5.44 5.44

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.